scholarly journals Hemodynamic characterization of focal hepatic lesions: Role of ferucarbotran-enhanced dynamic MR imaging using T2-weighted multishot spin-echo echo-planar sequence

2006 ◽  
Vol 23 (4) ◽  
pp. 509-519 ◽  
Author(s):  
Masatoshi Hori ◽  
Takamichi Murakami ◽  
Tonsok Kim ◽  
Riccardo Iannaccone ◽  
Hisashi Abe ◽  
...  
Radiology ◽  
1994 ◽  
Vol 193 (1) ◽  
pp. 59-65 ◽  
Author(s):  
Y Yamashita ◽  
Y Hatanaka ◽  
H Yamamoto ◽  
A Arakawa ◽  
T Matsukawa ◽  
...  

Radiology ◽  
2003 ◽  
Vol 226 (1) ◽  
pp. 71-78 ◽  
Author(s):  
Bachir Taouli ◽  
Valérie Vilgrain ◽  
Erik Dumont ◽  
Jean-Luc Daire ◽  
Bo Fan ◽  
...  

1995 ◽  
Vol 36 (2) ◽  
pp. 188-192 ◽  
Author(s):  
Y. Yamashita ◽  
M. Torashima ◽  
M. Takahashi ◽  
H. Mizutani ◽  
K. Miyazaki ◽  
...  

Conventional spin-echo (SE) and contrast-enhanced dynamic MR imaging were performed on a 1.5 T superconductive unit for evaluation of myometrial lesions in postmolar gestational trophoblastic disease (GTD) in 10 women. MR imaging was done at the time of the initial examination (n=10), during (n=6), and after repeated courses of chemotherapy (n=10). The T2-weighted SE image revealed an enlarged uterus (n=7), disappearance of zonal anatomy (n=6), and heterogeneous signal intensities (n=8) with prominent flow voids (n=7). However, these abnormalities remained after repeated courses of chemotherapy, when the S-β-HCG level returned to the normal range. Myometrial lesions characteristically had marked enhancement with areas of unenhancement on dynamic MR images in patients with highly elevated S-β-HCG. Areas of contrast enhancement correlated with changes in S-β-HCG level. The enhancement was reduced with decrease in S-β-HCG level after repeated courses of chemotherapy. Six of 8 masses seen on T2-weighted images proved to be active trophoblastic lesions and 2 masses proved to be hematoma or necrosis. In 2 patients, abnormal myometrial lesions were detected only on contrast-enhanced dynamic MR imaging. These preliminary data indicate that contrast-enhanced dynamic MR imaging more clearly demonstrates myometrial involvement of postmolar GTD than conventional SE imaging.


2003 ◽  
Vol 13 (5) ◽  
pp. 931-942 ◽  
Author(s):  
Olivier Rouvière ◽  
Anne Raudrant ◽  
René Ecochard ◽  
Catherine Colin-Pangaud ◽  
Carole Pasquiou ◽  
...  

2008 ◽  
Vol 60 (1) ◽  
pp. 25-29 ◽  
Author(s):  
Bhawna ◽  
Roy Santosham ◽  
Sujai Anand ◽  
Santhosh Joseph

2000 ◽  
Vol 18 (5) ◽  
pp. 543-551 ◽  
Author(s):  
Randolph S Pawluk ◽  
Joseph A Borrello ◽  
Jeffrey J Brown ◽  
Elizabeth G McFarland ◽  
Scott A Mirowitz ◽  
...  

Radiology ◽  
2003 ◽  
Vol 226 (2) ◽  
pp. 550-555 ◽  
Author(s):  
Ayame Shimizu ◽  
Katsuyoshi Ito ◽  
Shinji Koike ◽  
Takeshi Fujita ◽  
Kensaku Shimizu ◽  
...  

1993 ◽  
Vol 34 (3) ◽  
pp. 303-308 ◽  
Author(s):  
Y. Yamashita ◽  
S. Yoshimatsu ◽  
M. Sumi ◽  
M. Harada ◽  
M. Takahashi

The effect of transcatheter arterial chemo-embolization therapy (TACE) for hepatoma was evaluated with dynamic MR imaging with Gd-DTPA in 37 patients (44 tumors). TACE was performed using Lipiodol/cis-platinum and gelatin sponge (or microspheres) as an embolic material. All patients were examined with dynamic CT and MR imaging before and after treatment. On conventional spin echo images, changes of signal intensity after treatment varied regardless of presence of Lipiodol. Dynamic MR imaging revealed changes of tumor vascularity before and after treatment. On histologic correlation, areas of persistent tumor enhancement on dynamic MR imaging corresponded to areas of viable tumor cells while areas of nonenhancement corresponded to areas of necrosis. Dynamic MR imaging was superior in contrast resolution and was not influenced by the presence of Lipiodol compared with dynamic CT, and therefore residual viable tumors were better defined by dynamic MR imaging.


1993 ◽  
Vol 160 (5) ◽  
pp. 1011-1017 ◽  
Author(s):  
M A Goldberg ◽  
P F Hahn ◽  
S Saini ◽  
M S Cohen ◽  
P Reimer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document